慢性疼痛
5-羟色胺能
萧条(经济学)
医学
共病
三环
再摄取抑制剂
情绪障碍
心情
抗抑郁药
精神科
血清素
内科学
药理学
焦虑
宏观经济学
经济
受体
作者
Herlinda Bonilla‐Jaime,José A. Sánchez-Salcedo,Maribel M. Estévez-Cabrera,Tania Molina-Jiménez,José Luis Cortes-Altamirano,Alfonso Alfaro-Rodríguez
标识
DOI:10.2174/1570159x19666210609161447
摘要
Emotional disorders are common comorbid affectations that exacerbate the severity and persistence of chronic pain. Specifically, depressive symptoms can lead to an excessive duration and intensity of pain. Clinical and preclinical studies have been focused on the underlying mechanisms of chronic pain and depression comorbidity and the use of antidepressants to reduce pain.This review provides an overview of the comorbid relationship of chronic pain and depression, the clinical and pre-clinical studies performed on the neurobiological aspects of pain and depression, and the use of antidepressants as analgesics.A systematic search of literature databases was conducted according to pre-defined criteria. The authors independently conducted a focused analysis of the full-text articles.Studies suggest that pain and depression are highly intertwined and may co-exacerbate physical and psychological symptoms. One important biochemical basis for pain and depression focuses on the serotonergic and norepinephrine system, which have been shown to play an important role in this comorbidity. Brain structures that codify pain are also involved in mood. It is evident that using serotonergic and norepinephrine antidepressants are strategies commonly employed to mitigate pain Conclusion: Literature indicates that pain and depression impact each other and play a prominent role in the development and maintenance of other chronic symptoms. Antidepressants continue to be a major therapeutic tool for managing chronic pain. Tricyclic antidepressants (TCAs) are more effective in reducing pain than Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin- Noradrenaline Reuptake Inhibitors (SNRIs).
科研通智能强力驱动
Strongly Powered by AbleSci AI